Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate
Year: 2013
Type: article
Abstract: The investigation of metabolic pathways disturbed in isocitrate dehydrogenase (IDH) mutant tumors revealed that the hallmark metabolic alteration is the production of D-2-hydroxyglutarate (D-2HG). The biological impact of D-2HG strongly suggests that high levels of this metabolite may play a central role in propagating downstream the effects of mutant IDH, leading to malignant transformation of cells. Hence, D-2HG may be an ideal biomarker for both diagnosing and monitoring treatment response targeting IDH mutations. Magnetic resonance spectroscopy (MRS) is well suited to the task of noninvasive D-2HG detection, and there has been much interest in developing such methods. Here, we review recent efforts to translate methodology using MRS to reliably measure in vivo D-2HG into clinical research.
DOI: 10.1172/jci67229
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: G1220546045, SPECTROSCOPY/IMAGING CONSOLE FOR STUDIES AT 94 TESLA, G2268713923, G338756917, G3549079774, Clinical and Molecular Studies of Malignant Brain Tumors, G653110949, Quantify treatment response in IDH1 mutant glioma patients with metabolic MRI, G7499259106, A Siemens MAGNETOTOM Trio 3 Tesla MRI System, A Storage Area Network for Structural and Functional Image Analysis, G8998766674, G9000037461, G9000041374, G9000165426, Training Program in Nervous System Tumors, G953382460, G979501398
OpenAlex ID: W2074448607
